Synairgen plc’s £87 Million Fundraising

Paolo Bossi

Fieldfisher has advised Synairgen plcon its £87 million fundraising to begin the Phase III trial for a potential inhaled treatment for COVID-19. The fundraising was structured…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now